In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Boehringer Ingelheim ties earn-outs to $515mm Actimis buy

Executive Summary

Boehringer Ingelheim has agreed to acquire Actimis Pharmaceuticals after the private start-up's lead candidate AP768 reaches certain development milestones.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Preliminary
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Earnout
    • Payment Includes Cash

Related Companies